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4-phenylbutyrate (4-PB) has been shown to increase the protein content in a number of
cells types. One such protein is Connexin43 (Cx43). We show here that 4-phenylbutyrate
exposure results in significantly elevated cell to cell coupling, as determined by dual whole
cell patch clamp. Incubation with 5mM 4PB for 24 h or more nearly doubles junctional
conductance. Interestingly, mRNA levels for Cx43 declined with exposure to 4-PB while
western blot analysis revealed not significant change in protein levels. These data are
most consistent with stabilization of the existing Cx43 pool or alterations in the number
of functional channels within an existing pool of active and silent channels. These data
represent a baseline for testing the efficacy of increased connexin mediated coupling in a
variety of multicellular functions including erectile function.
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INTRODUCTION
Corpora Cavernosa smooth muscle cells form a functional syn-
cytium as a consequence of connexin derived gap junction
channels connecting cell interiors (Harris, 2001). The most ubiq-
uitously expressed connexin gene in corpora smooth muscle is
Connexin43 (Cx43) (Asklund et al., 2004). Reduced expression of
connexins has been implicated as a major contributor to impaired
function with reduced expression of connexins (Melman and
Christ, 2001). Further, a number of studies strongly suggest that
Cx43 expression and gap junctionmediated coupling are essential
for relaxation of corpora smooth muscle cells and hence erec-
tile response (Christ and Lue, 2004; Pointis, 2006; Fu et al., 2008;
Suadicani et al., 2009).
A relevant question becomes: can up-regulation or enhanced
functionality of Cx43 lessen erectile dysfunction? To assess this
possibility it is first necessary to assess Cx43 expression and
junctional conductance in corpora smooth muscle cell pairs.
Up-regulation of connexin expression can be accomplished
with exposure to mild hyperthermia (VanSlyke and Musil, 2005).
The expression of adhesion molecules such as alpha and beta
catenin and cadherin can also affect connexin expression (Jongen
et al., 1991; Prowse et al., 1997; Wei et al., 2005) and organ
function (Ferreira-Cornwell et al., 2002; Li et al., 2006). The
antiarrhythmic peptide ZP123 (Rotigaptide) has also been to
shown to increase junctional conductance in cardiac myocyte
pairs asmuch as 69%withinminutes (Eloff et al., 2003; Xing et al.,
2003; Axelsen et al., 2006) but it has not been shown to affect
expression levels suggesting that it acts to recruit channels from a
silent pool. The idea of a silent reservoir is based on the fact that
active Cx43 channels in corpora have been shown to have open
probabilities approaching between 0.5 and unity (Brink et al.,
1996; Christ and Brink, 1999).
Another choice is chemical stimulation with 4-PB (Asklund
et al., 2004) that inhibits histone deacetylases (HDACs), enzymes
associated with inactivation of gene transcription (Perlmutter,
2002; Asklund et al., 2004; Iwasaki et al., 2006). 4-PB is an
FDA approved drug that can be administered orally and is cur-
rently being tested for effectiveness in spinal muscular atrophy
(Wirth et al., 2006), cystic fibrosis (Singh et al., 2006), and can-
cer (Tang et al., 2004). In vitro studies on cancer cell lines are of
particular interest as they suggest Cx43 up-regulation results in
channel recruitment. Asklund et al. (2004) found that 5mM 4-PB
increased Cx43 expression two- to five-fold with exposure times
of hours to days in human glioblastoma cells and also reduced
proliferation rate two- to three-fold and Khan et al. (2007) found
that 4-PB induced apoptosis in human glioma cells. 4-PB has also
been shown to elevate Cx43 expression in both Cx43 transfected
cells (HeLa) and cells that endogenously express Cx43 (HEK-293)
(Kaufman et al., 2013). All three studies also noted that exposure
to 4-PB enhanced fluorescent dye transfer between cells consis-
tent with an increase in the number of functional gap junction
channels linking cell interiors.
We have used dual whole cell patch clamp to monitor
junctional conductance in rat corpora cavernosa cell pairs to
determine if 4PB exposure caused junctional conductance to
increase between corpora smooth muscle cell pairs. We also
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monitored 4-PB effects on Cx43 expression using real-time PCR
and Western Blot. We observed no significant change Cx43
protein levels contrary to previous reports (Asklund et al.,
2004; Khan et al., 2007; Kaufman et al., 2013) but found that
junctional conductance increased 1.4-fold after 24 h of expo-
sure and attained a maximum increase of 1.8-fold after 72 h of
exposure to 4PB. Voltage dependence was not affected by 4PB.
METHODS
CELL SOURCE
Rat corporal tissue was dissected from the rat penis as previously
described (Rehman et al., 1997; Wang et al., 2001). Explant cul-
tures of rat corporeal cells were prepared as follows. Short-term
cultures, i.e., passages 0–2, were prepared from freshly isolated
rat corporeal myocytes (Wang et al., 2001) Cells were plated on
35mm dishes and allowed to attach and proliferate for 1–2 days
(passage 0) or they were split upon confluence (passage 1) prior
to trypsinization and resuspension onto cover dishes for patch
clamp analysis (Rehman et al., 1997; Wang et al., 2001).
PATCH CLAMP
Dual whole cell patch clamp of cell pairs was used as previ-
ously described (Wang et al., 2001; Valiunas et al., 2002). Media
was exchanged for a buffered solution containing 150mM NaCl,
4mM KCl, 1mM MgCl2, 5mM HEPES, 2mM pyruvate, and
2mM CaCl2, pH 7.2 containing no 4-PB. The pipette solu-
tion contained 130mM KCl, 10mM NaCl, 1mM MgCl2, 10mM
egtazic acid and 1mM CaCl2, pH 7.0. Pipette resistance varied
from 2 to 5 M. Step protocols to monitor junctional conduc-
tance were as previously described (Wang et al., 2001). Data
analysis was performed as previously described to determine volt-
age dependence, and junctional conductance (Valiunas et al.,
2001; Wang et al., 2010).
WESTERN BLOT
Rat corpora smooth muscle cells or rat mesenchymal stem
cells were exposed to 4-PB at concentrations of 0, 1, or 5mM
for 48 h. Cells were collected from cultures by first washing
then scraping in cold PBS. Cell suspensions were centrifuged
at 14,000 rpm at 4◦C for 10min then the supernatants were
removed. The pellets were resuspended in cold RIPA (Radio-
Immnuoprecipitation Assay) buffer (R0278, Sigma), protease
inhibitor cocktail (AEBSF, Aprotinin, Bestatin hydrochloride, E-
64, EDTA, Leupeptin) (P2714, Sigma), sodium orthovanadate
(S-6508, Sigma) and PMSF (P-7626, Sigma). Samples were kept
on wet ice during the lysis step for ∼30min and frequently vor-
texed. Samples were then centrifuged in an Eppendorf microfuge
at 4◦C, 14,000 rpm for 10min, supernatants were transferred to
new pre-chilled microtubes. Protein concentration of the sam-
ples was determined by the Bradford assay. Volumes containing
30μg of total protein for each dose point were mixed with equal
volumes of Laemmli sample buffer (161-0737, Bio Rad) contain-
ing β-mercaptoethanol and boiled for 5min at 95◦C. All samples
were cooled then centrifuged briefly before being loaded on a
SDS-polacrylamide gel (4% stacking gel, 10% separating gel).
After separation by electrophoresis at 115V for 90min in tris-
glycine/SDS buffer, proteins were transferred to Immobilon-P
membrane (Millipore) by electrophoresis at 100V for 60min in
tris-glycine/methanol buffer. Non-specific antibody binding was
blocked for 1 h at RT in 5% Blotting Grade Blocker non-fat dry
milk (Bio Rad) dissolved in 1x TBST. The membrane was washed
briefly in 1x TBST (Wang et al., 2010).
For Cx43: a 43 kDa protein was probed for by incubating the
membrane with the anti-connexin 43 antibody (C 6219, Sigma)
at 1:8000 in 1% milk for 1 h at room temperature. After washing
the membrane well with 1x TBST the membrane was incu-
bated for 1 h at room temperature with goat anti-rabbit IgG-HRP
(sc-2004, Santa Cruz) at 1:10,000 in 1% milk. After washing
the membrane well with 1x TBST the secondary antibody was
detected using SuperSignal West Femto Maximum Sensitivity
Substrate (34095, Pierce) and images obtained by exposing the
membrane to HyBlot CL Autoradiography Film (E3012, Denville
Scientific).
For Tubulin a 55 kDa protein was probed for by incubating
the membrane for 1 h at room temperature with Anti-α-Tubulin
(sc-8035, Santa Cruz) at 1:1000 in 1% milk. After washing the
membrane well with 1x TBST the membrane was incubated
for 1 h at room temperature with goat anti-mouse IgG-HRP
(1858413, Pierce) at 1:10,000 in 1%milk. After washing the mem-
brane well with 1x TBST the secondary antibody was detected
using SuperSignal West Femto Maximum Sensitivity Substrate
(34095, Pierce) and images obtained by exposing the membrane
to HyBlot CL Autoradiography Film.
The Western blot results were evaluated by making compar-
isons between bands in different lanes. Quantification of the
intensity of the protein bands seen on the x-ray film was done
using the free NIH ImageJ software. First a digital image of the
film was made with a scanner then converted to gray scale. A rect-
angular box was drawn around the first band and selected, the box
was then moved to each of the other bands and again selected.
Once all were selected the bands were then plotted which gener-
ated a graphical depiction of band intensities. Using the draw line
tool each band histogram was marked off at its base. The magic
wand tool was clicked inside each histogram, after each peak was
selected, label peaks was clicked which generated numerical values
of band intensities. The same procedure was done for the load-
ing control and the experimental data was normalized resulting
in adjusted density values.
RNA EXTRACTION AND REAL-TIME PCR
Total RNA was extracted from control and 4-PB treated cor-
pora smooth muscle cell cultures (RNeasy Miniprep Kit, Qiagen,
Valencia, CA). Three independent 100-mm diameter culture
dishes were used for each experimental condition. The RNA sam-
ples were quantitated by optical density measurement and then
diluted to the same nominal concentration. A second round of
optical density measurement was performed to confirm the accu-
racy of this step. Five milligrams of RNA was used for cDNA syn-
thesis (Superscript III reverse transcriptase, Life Technologies).
The cDNA samples were diluted 1:16 prior to real-time PCR
analysis.
Real-time PCR was performed with a StepOne Plus instru-
ment (Life Technologies) using the QuantiFast SyBr Green PCR
chemistry (Qiagen), as described previously (Rosati et al., 2011).
The reaction mixture for each sample included the SyBr Green
mastermix, 8μL of cDNA and 1.25mM of each gene-specific
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primer. The fast PCR amplification included a 5min activating
step at 95◦C, and 40 cycles of denaturation (95◦C for 10 s)
and annealing–extension (60◦C for 27 s). Expression values were
extracted automatically from the raw fluorescence data using a
custom analysis program (Python/PyQt) with a standard thresh-
old crossing algorithm (Ruijter et al., 2013). Multiple different
primer pairs were prescreened and only combinations with sim-
ilar amplification efficiencies were used in the experiments. The
18S and 28S RNAs were used as internal controls, since expres-
sion of these did not vary significantly between the samples.
Gene expression values were normalized to the average of the
18S and 28S expression values in each sample and expressed as
relative values. Connexin 43 and internal control gene expres-
sion was analyzed using two gene-specific primer pairs per gene.
The expression values obtained with each of the two pairs of
primers were very similar and were averaged to obtain the final
gene expression values.
The 5′–3′ gene-specific primer sequences were:
Cx43(1) fwd: CGCCGGCTTCACTTTCATTA, rev:
TTGTCCAGAAGCTTCCCCAA
Cx43(2) fwd: AGACTGCTTCCTCTCACGTC, rev:
AAAGCGAGAGACACCAAGGA
18S(1) fwd: CTCAGCGTGTGCCTACCCTA, rev:
GACCCGCACTTACTGGGAT
18S(2) fwd: CGGAACTGAGGCCATGATTA, rev:
CTTTCGCTCTGGTCCGTCTT
FIGURE 1 | Western blot of corpora cavernosa smooth muscle cells.
The western blot shows the effect of 4PB after 48 h exposure at
concentrations of 0 (lane 1), 1mM (lane 2), and 5mM (lane 3). The reporter
protein used was tubulin along with Cx43. Three examples are shown.
From top to bottom – increased expression, no change and reduced
expression. The average value for six Western blots using ImageJ analysis
was 0.93 ± 0.25 SD of controls.
28S(1) fwd: CTCCGAAGTTTCCCTCAGGA, rev:
GGCCCCAAGACCTCTAATCA
28S(2) fwd: AGGACCCGAAAGATGGTGAA, rev:
TCGCCCCTATACCCAGGTC
Primers were designed using the Primer3 software (MIT: http://
primer3.ut.ee). All primer pairs were validated by electrophoresis
analysis of the amplicons and the amplicons were sequenced to
verify gene specificity.
RESULTS
Western blot analysis showed that exposure to 4-PB resulted in
no change in Cx43 protein levels in rat corpora smooth muscle
cells. Image analysis was performed on six western blots where
controls (no 4PB) were compared to 4PB expose preparations.
Exposure time to 4PB was 48 h yielding an average value of 0.93
± 0.25 (SD) for 4PB exposed cells expressing Cx43. Figure 1
compares Cx43 protein levels along with a reporter gene, tubu-
lin from three experiments illustrating the variability of Cx43
expression. In total six Western blot experiments were done and
in each case normalized against a control (no 4-PB). 4-PB is not
a specific enhancer of expression but rather a general tool able to
modify the expression of some but not all proteins within a cell.
Neither Cx43 nor tubulin expression was demonstrably affected
by 4PB. In other cell systems increases of Cx 43 have been reported
(Asklund et al., 2004; Kaufman et al., 2013). Transcription level
for Cx43 was also determined.We quantified Cx43mRNA expres-
sion in control and 4-PB treated cells 24 and 48 h after addition
of the drug/vehicle (Figure 2). There was a 56% increase in Cx43
mRNA expression in the control corpora cells at 48 h compared to
FIGURE 2 | Effect of 4-PB treatment on Cx43 mRNA expression in
corpora cells. Real-time PCR analysis of the Cx43 gene expression in Frc
cells treated with vehicle (Control) and 5mM of the drug (4-PB) for 24 and
48 h. The columns represent average expression values (normalized to the
24 h control) and the bars are s.e.m. (n = 3).
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FIGURE 3 | Dual whole cell patch clamp of corpora cell pair. (A) Junctional
currents recorded in one cell of a pair generated in response to voltage steps
in the other. Upper records are junctional current, lower record shows the
voltage steps. (B) Steady state junctional conductance (Gss/GInst) plotted
against transjunctional voltage step as previously described (Wang et al.,
2010). Filled circles are the data shown in A. All data points are from four
different cell pairs exposed 4PB (5mM) for 24 h (n = 4). Boltzmans fit of the
4PB data set yielded a Vo of 67mV, a gmin of 0.33. The dashed line
represents a Boltzmans fit of control data with the following parameters:
Vo = 67mV and gmin = 0.31.
FIGURE 4 | Summary plot of 4-PB exposed cell pairs and controls over
time using a 5mM concentration. Three-hour time point: controls n = 4,
4PB: n = 3; 24 h time point: controls: n = 24, 4-PB: n = 74; 48 h: controls:
n = 9, 4PB: n = 37; 72 h: controls: n = 18, 4-PB: n = 38; 96 h controls:
n = 13, 4PB: n = 19. Thirty four cell pairs exposed to 4-PB were studied at
120 h. There was no statistical difference (T -test) between controls and
4-PB at 3 h but for 48, 72, and 96 h the P-values were all <0.037. Means
and standard errors are plotted.
the 24 h controls (p < 0.01). Cx43 mRNA expression in the other
three cell groups was not significantly different to each other.
The increase in Cx43 mRNA expression with time in cul-
ture was prevented by 4-PB treatment, resulting in unchanged
Cx43 mRNA levels compared to the 24-h expression level and
significantly lower expression relative to the 48-h control cells.
Figures 1, 2 taken together suggest that 4-PB, stabilizes Cx43
through an as yet unidentified post-transcriptional mechanism.
4-PB did not affect the voltage dependence of junctional con-
ductance nor was any change in steady state Gj vs. Vj observed
relative to untreated corpora cell pairs (Rehman et al., 1997;Wang
et al., 2001). To demonstrate voltage dependence cell pairs with
junctional conductance of 10 nS or less were chosen to minimize
error due to series resistance. Figure 3A illustrates an example of
junctional current (Ij) generated in response to transjunctional
voltage steps from a cell pair exposed for 48 h to 5mM of 4-PB.
Voltage dependent behavior was identical for 4PB and controls.
Figure 3B shows the steady state normalized Gj–Vj relationship
for the data shown in Figure 3A and control data as well.
To assess whether 4PB resulted in an increase in junctional
conductance it was necessary to generate a database where average
junctional conductance was determined at various time points
during exposure to 4-PB. The data shown in Figure 4 illustrates
that exposure to 4-PB resulted in increased junctional conduc-
tance relative to controls. The time course with and without 4-PB
over a 5 days period is illustrated. In all cases cells were plated
out and then exposed to 5mM 4-PB or received an equivalent
value of media (control) and at various times points dual whole
cell patch clamp was performed to assess the magnitude of junc-
tional conductance. The time course to reach an apparent steady
state is approximately the same but the extent of coupling is ∼2×
greater with 4-PB exposure. In transfected HeLa cells and HEK
cells 4PB increased junctional conductance ∼1.44 over controls
(Kaufman et al., 2013). The data are consistent with a stabilization
of Cx43 channels such that the degradation rate is slowed relative
to the insertion rate. An alternative explanation is an increase in
the number of functional channels arising out of a pool of intact
but normally silent channels.
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DISCUSSION
These data demonstrate 4-PB exposure results in enhanced junc-
tional conductance (∼2X) consistent with previous observations
on other cell types (Asklund et al., 2004; Khan et al., 2007;
Kaufman et al., 2013). It is also clear from the gene expression
data that post-transcriptional mechanisms dominate in deter-
mining the final level of functional Cx43 protein expression since
mRNA levels are significantly reduced (Figure 2). Up-regulation
of Cx43 protein expression and function has been documented
in several cell types, by our group and others (Ammerpohl et al.,
2004; Asklund et al., 2004; Hattori et al., 2007; Khan et al., 2007;
Kaufman et al., 2013). In marked contrast here we find no change
in apparent protein expression while Cx43 mRNA expression is
decreased following 48-h treatment with 4-PB, as has also been
observed by Hattori et al. (2007).
It has been suggested that HDAC inhibitors might increase
Cx43 translation or stabilize the existing pool of proteins (Hattori
et al., 2007) and our data are consistent with this hypothesis, sug-
gesting that functional Cx43 channels are the end result of broad
effects of HDAC inhibition on the network of genes controlling
Cx43 translation and post-translational expression.
The apparent down-regulation of Cx43 mRNA at 48 h in cul-
ture may also reflect network effects of the drug or could be
an example of a weak negative feedback control, by which an
increase in Cx43 protein leads to a modest decrease in mRNA
transcription.
Another possibility to explain the enhanced junctional con-
ductance is an increased channel open time for a population
of channels but this is a less likely explanation based on previ-
ous studies using corpora smooth muscle cell pairs where open
probability of Cx43 was shown to approach unity (Brink et al.,
1996; Christ and Brink, 1999; Wang et al., 2001) even with
substantial applied transjunctional potentials. It is also possible
that increased junctional conductance is the result of recruit-
ment or activation of intact but silent channels to a functional
state (Bukauskas et al., 2000). How 4-PB might trigger such an
occurrence is not clear.
The lack of effect on voltage dependence and the steady state
Gj–Vj relationship also suggests that expression of other connex-
ins was not significant. The Gj–Vj plot shown in Figure 3 is the
same as records previously published for rat corpora cell pairs
(Wang et al., 2001) suggesting that the profile of connexin expres-
sion was not altered by 4-PB. It is possible that the expression of
other connexins is occurring with exposure to 4-PB but the per-
centage of functional channels other than Cx43 must be small.
If there were significant expression of other connexin types the
resultant Gj–Vj plot would be different due to the presence of
other homotypic channels and/or heterotypic channels (Brink
et al., 1997, 2000) We were unable to monitor single channel
conductance from cell pairs that were exposed for 24 h or more
because the macroscopic junctional conductance was elevated
to junctional conductances above 10 nS where it is impossible
to directly observe single channel activity. But in a recent study
(Kaufman et al., 2013) Cx43 unitary conductance was shown to
be unaffected by 4-PB exposure. The data also suggested that there
was little or no change in open time probability for Cx43 gap
junction channels.
Aging, diabetes, and hypertension all result in reduced expres-
sion of Cx43 in animal models and in human males and all three
are associated with a higher incidence of erectile dysfunction
(Pointis, 2006). Present approaches to alleviate erectile dysfunc-
tion center on the therapeutic inhibition of phosphodiesterase V
(PDE5) resulting in elevated cGMP concentrations that then trig-
ger relaxation by reducing cytoplasmic calcium levels. 4PB and
other related derivatives (Shieh et al., 2012) represent an alterna-
tive potential therapy for erectile dysfunction that acts to enhance
protein expression by inhibition of HDAC. The use of HDAC
inhibitors as a treatment for other conditions such as diabetes
and hypertension is also possible if Cx43 expression or other rele-
vant proteins in those diseases can be shown to reduce symptoms
(Shieh et al., 2012).
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